Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Giudici

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Minerva Anestesiologica|May 19, 2000
Customization of SAPS II for the assessment of severity in Italian ICU patients. ARCHIDIA. Archivio DiagnosticoA Sicignano, D Giudici
The Journal of Trauma|November 14, 1997
Probability model of hospital death for severe trauma patients based on the Simplified Acute Physiology Score I: development and validation. Archivio DiagnosticoA Sicignano, D Giudici
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1993
Inhibitory effect of combined treatment with the aromatase inhibitor exemestane and tamoxifen on DMBA-induced mammary tumors in ratsT Zaccheo, D Giudici, E Di Salle
The Journal of Steroid Biochemistry and Molecular Biology|May 30, 1998
Effect of the dual 5alpha-reductase inhibitor PNU 157706 on the growth of dunning R3327 prostatic carcinoma in the ratT Zaccheo, D Giudici, E di Salle
The Prostate|June 3, 1998
Effect of early treatment of prostate cancer with the 5alpha-reductase inhibitor turosteride in Dunning R3327 prostatic carcinoma in ratsT Zaccheo, D Giudici, E di Salle
The Prostate|February 1, 1997
Effect of turosteride, a 5 alpha-reductase inhibitor, on the Dunning R3327 rat prostatic carcinomaT Zaccheo, D Giudici, E di Salle
Endocrine-Related Cancer|October 12, 1999
Combined treatment with the 5 alpha-reductase inhibitor PNU 157706 and the antiandrogen flutamide on the Dunning R3327 prostatic carcinoma in ratsT Zaccheo, D Giudici, E di Salle
Minerva Anestesiologica|June 8, 2004
[Infection surveillance in intensive care units. Preliminary results of a multicenter GiViTI study in 71 Italian ICUs]P Malacarne, A Stella, D Giudici, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2000
Combined treatment of Dunning R3327 rat prostatic tumor with the 5alpha-reductase inhibitor PNU 157706 and the antiandrogen bicalutamideT Zaccheo, D Giudici, A Panzeri, et al.
Chemotherapy|July 29, 1998
Effect of the 5 alpha-reductase inhibitor PNU 156765, alone or in combination with flutamide, in the Dunning R3327 prostatic carcinoma model in ratsT Zaccheo, D Giudici, A Panzeri, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Minerva Anestesiologica|May 19, 2000
Customization of SAPS II for the assessment of severity in Italian ICU patients. ARCHIDIA. Archivio DiagnosticoA Sicignano, D Giudici
The Journal of Trauma|November 14, 1997
Probability model of hospital death for severe trauma patients based on the Simplified Acute Physiology Score I: development and validation. Archivio DiagnosticoA Sicignano, D Giudici
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1993
Inhibitory effect of combined treatment with the aromatase inhibitor exemestane and tamoxifen on DMBA-induced mammary tumors in ratsT Zaccheo, D Giudici, E Di Salle
The Journal of Steroid Biochemistry and Molecular Biology|May 30, 1998
Effect of the dual 5alpha-reductase inhibitor PNU 157706 on the growth of dunning R3327 prostatic carcinoma in the ratT Zaccheo, D Giudici, E di Salle
The Prostate|June 3, 1998
Effect of early treatment of prostate cancer with the 5alpha-reductase inhibitor turosteride in Dunning R3327 prostatic carcinoma in ratsT Zaccheo, D Giudici, E di Salle
The Prostate|February 1, 1997
Effect of turosteride, a 5 alpha-reductase inhibitor, on the Dunning R3327 rat prostatic carcinomaT Zaccheo, D Giudici, E di Salle
Endocrine-Related Cancer|October 12, 1999
Combined treatment with the 5 alpha-reductase inhibitor PNU 157706 and the antiandrogen flutamide on the Dunning R3327 prostatic carcinoma in ratsT Zaccheo, D Giudici, E di Salle
Minerva Anestesiologica|June 8, 2004
[Infection surveillance in intensive care units. Preliminary results of a multicenter GiViTI study in 71 Italian ICUs]P Malacarne, A Stella, D Giudici, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2000
Combined treatment of Dunning R3327 rat prostatic tumor with the 5alpha-reductase inhibitor PNU 157706 and the antiandrogen bicalutamideT Zaccheo, D Giudici, A Panzeri, et al.
Chemotherapy|July 29, 1998
Effect of the 5 alpha-reductase inhibitor PNU 156765, alone or in combination with flutamide, in the Dunning R3327 prostatic carcinoma model in ratsT Zaccheo, D Giudici, A Panzeri, et al.
Pageof 5